Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

A toast to BRD4: How acidity changes the immune response

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory," recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, ...

Promising drug can inhibit aggressive breast cancer

New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.

How colorectal cancer evades immunotherapy using a dual barrier

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...

Lung cancer's earliest stages may be driven by inflammation

By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at The University of Texas MD Anderson Cancer Center have discovered that the earliest stages of lung ...

Thunderstorms linked to surge in asthma ER visits

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma. The research is being presented ...

People with allergies or eczema may face higher risk of surgical complications

Two new studies being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) show that people with allergic conditions—including eczema, asthma, and hay fever—may ...

Todays Updates

Husbands' self-esteem linked to lower risk of preterm birth in partners

A husband's optimism and confidence may play a crucial, if often unseen, role in helping babies arrive healthy and on time.

Combination immunotherapy helps overcome melanoma treatment resistance

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...

'Mind-captioning' technique can read human thoughts from brain scans

Reading brain activity with advanced technologies is not a new concept. However, most techniques have focused on identifying single words associated with an object or action a person is seeing or thinking of, or matching ...

Yes, you do need to clean your water bottle. Here's why and how

You keep your trusty reusable bottle filled with only clear, delicious water. Do you still need to wash it?

Study finds outpatient dialysis program cuts emergency hospital visits in Texas

The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in a significant decrease ...

New survey shows what people fear most about aging

The U.S. population is getting older fast and many Americans are unsure what aging will look like for them, a new national survey shows.

Todays Updates

Husbands' self-esteem linked to lower risk of preterm birth in partners

A husband's optimism and confidence may play a crucial, if often unseen, role in helping babies arrive healthy and on time.

Combination immunotherapy helps overcome melanoma treatment resistance

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...

'Mind-captioning' technique can read human thoughts from brain scans

Reading brain activity with advanced technologies is not a new concept. However, most techniques have focused on identifying single words associated with an object or action a person is seeing or thinking of, or matching ...

Yes, you do need to clean your water bottle. Here's why and how

You keep your trusty reusable bottle filled with only clear, delicious water. Do you still need to wash it?

Study finds outpatient dialysis program cuts emergency hospital visits in Texas

The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in a significant decrease ...

New survey shows what people fear most about aging

The U.S. population is getting older fast and many Americans are unsure what aging will look like for them, a new national survey shows.

Latest News

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory," recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, ...

New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...

By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at The University of Texas MD Anderson Cancer Center have discovered that the earliest stages of lung ...

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma. The research is being presented ...

Two new studies being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) show that people with allergic conditions—including eczema, asthma, and hay fever—may ...

News All Time

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, estrogen receptor-positive ...

Why cancer immunotherapy isn't effective for everyone

A study led by André Veillette, a researcher at the Montreal Clinical Research Institute (IRCM) and a professor in the Faculty of Medicine at University of Montreal, sheds new light on the complexity of the immune system ...

Study finds promising first evidence of targeted therapy for NRAS-mutant melanoma

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and activate the immune system, offering the first targeted approach for patients with NRAS-mutant melanoma, ...

Nerve injuries can affect the entire immune system, study finds

Nerve injuries can have long-lasting effects on the immune system that appear to differ between males and females, according to preclinical research from McGill University.

From blood to solid tumors: A new way to power up CAR T cell therapy

Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, ...

Sugars on immune cells, not just blood vessel walls, may regulate the inflammatory disease process

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the inflammatory disease, psoriasis.

People abused by intimate partners have worse asthma—researchers are still investigating this surprising link

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

Poison ivy, poison oak and poison sumac rash

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

VEXAS syndrome research reveals overactive bone marrow stem cells may drive inflammation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome—shedding new light on its mechanisms ...

Turning on an immune pathway in tumors could lead to their destruction

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Antibody therapy foils pancreatic cancer's sugar-based disguise to reawaken immune system

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

Immunotherapy resistance in kidney cancer driven by myeloid cell signaling

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.

Researchers unravel mystery behind rare pregnancy disorder

Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others. Their discovery opens the door to a test that could identify severe cases during pregnancy. Fortunately, ...

DNA copy-number changes help melanoma develop resistance to immunotherapy, study finds

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential strategy to prevent or reverse ...

Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?

A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they're all still alive. Scientists say that kind of long-term survival is almost unheard of for patients ...

How Staph aureus reshapes immune system in children with rare genetic skin disorder

Scientists have demonstrated for the first time how Staphylococcus aureus—a leading cause of skin infections—reshapes the immune system's inflammatory responses in children with a rare skin condition.

Recommended News For You

The Kansas Cancer Center awarded two Indian American doctors professorships.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Ineffective medication can remove the "worst fear" of schizophrenia.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

A computer-aided diagnostic system for improved detection of breast cancer.

Spouses of Cancer Patients May Be at Increased Risk of Suicide

Study recommends new grading system for invasive squamous cell carcinoma of the lung

Recommended Articles For You

Exploring the Use of Bevacizumab in Treating Different Types of Cancers  

Exploring the Role of Fecal Leukocytes in Intestinal Health 

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI-based breast cancer risk technology receives FDA breakthrough device designation

2.

automated, precise reporting for clonality testing using NGS.

3.

Cancer screening rates down among American adults

4.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

5.

Providing essential cancer care to rural communities

1.

Exploring the Role of Fecal Leukocytes in Intestinal Health

2.

Unlocking The Causes And Risk Factors Of Breast Cancer

3.

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients

4.

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction 

5.

Understanding Axitinib: What You Need To Know For Your Treatment Plan

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot